AGP Executive Report
Last update: 4 hours agoNvidia Shake-Up: Jensen Huang’s immediate departure sent shares lower, wiping more than $320 billion from the chipmaker’s value in one day. CFO Colette Kress is interim CEO as the board weighs a successor. Biotech Finance: Nasdaq remains the sector’s go-to exchange: 515 of 531 U.S. biotech and pharma IPOs from 2015 to 2024 listed there. But 2026’s returning IPO market has brought mixed first-day results, underscoring that a Nasdaq listing is no guarantee of investor enthusiasm. Manufacturing: Canfor’s third-quarter adjusted EBITDA improved to $1.5 million from a $12.2 million loss in the prior quarter, but weak pulp markets are driving the permanent closure of its Northwood mill in British Columbia. SME Support: Malaysia is pitching closer business ties with China and says its 2027 budget includes RM67.9 billion for small and midsize businesses, along with tax cuts and a minimum-wage increase exemption. Business Services: Hawaiʻi’s online registration system has left companies facing four-month delays and a backlog of 40,000 filings as the state works to fix technical problems.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.